Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
From Benzinga
Johnson & Johnson's COVID-19 Vaccine Less Effective Against Hospitalization, French Study Shows
March 03, 2022
From Benzinga
Pfizer/BioNTech's COVID-19 Vaccine Mere 12% Effective In Kids 5-11 Years, New York Study Shows
March 01, 2022
From Benzinga
RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients
March 01, 2022
Tickers
RDHL
From Benzinga
Cardiol Therapeutics To Include Vaccinated Participants In Cannabidiol COVID-19 Trial
March 01, 2022
Tickers
CRDL
From Benzinga
From Benzinga
Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests
February 25, 2022
From Benzinga
Canada Approves First Plant-Based COVID-19 Vaccine
February 25, 2022
From Benzinga
Chimerix's CMX521 Antiviral Program Shows Potential Against COVID-19 In Preclinical Studies
February 24, 2022
Tickers
CMRX
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Adagio Lays Out Development Plans For COVID-19-Focused ADG20 Program
February 22, 2022
Tickers
ADGI
From Benzinga
Valneva Secures £20M From Scottish Enterprise For Vaccine Development
February 22, 2022
Tickers
VALN
From Benzinga
FDA Lifts Clinical Hold On Ocugen's COVID-19 Vaccine Study In US
February 22, 2022
Tickers
OCGN
From Benzinga
See Why Did FDA Update Merck's COVID-19 Pill Emergency Use Authorization
February 18, 2022
From Benzinga
From Benzinga
Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters
February 17, 2022
Tickers
MRNA
From Benzinga
South Africa Authorizes Merck's COVID-19 Antiviral Pill, But Government Not Buying: Reuters
February 17, 2022
From Benzinga
Regencell Bioscience's COVID-19 Candidate Shows Encouraging Action On Mild To Moderate Symptoms
February 17, 2022
Tickers
RGC
From Benzinga
Short Shelf Life Of AstraZeneca's COVID-19 Shot Entangles Vaccine Rollout In Poorer Nations: Reuters
February 16, 2022
From Benzinga
Enanta Pharma Commences Dosing In Phase 1 COVID-19 Trial
February 16, 2022
Tickers
ENTA
From Benzinga
Moderna-Rovi Seal 10-Year Deal Extension To Make mRNA Drugs
February 16, 2022
Tickers
MRNA
From Benzinga
Pfizer, Moderna COVID-19 Boosters Effectiveness Wanes After Four Months: CDC Study
February 14, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.